Neurologic and psychiatric complications of antiretroviral agents

Charles Raines, Olivia Radcliffe, Glenn J. Treisman

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Advances in highly active antiretroviral therapy (HAART) aim to improve the efficacy of HIV drugs as well as the quality of life in HIV-infected patients. Neurologic and psychologic disturbances that occur because of HIV disease and therapy are of great concern, and because they can overlap and are often difficult to distinguish, their pathogenesis is not clearly understood. Furthermore, these complications can lead to decreased adherence, thereby interfering with treatment outcomes. Antiretrovirals, including nonnucleoside reverse transcriptase inhibitors, can penetrate the central nervous system (CNS) and suppress viral replication, but they can also exacerbate CNS side effects and neuropsychiatric symptoms. When deciding which HAART drug combination is most appropriate for a patient, clinicians must consider the individual's risk of CNS complications together with the efficacy of the specific HAART regimen.

Original languageEnglish (US)
Pages (from-to)35-48
Number of pages14
JournalJournal of the Association of Nurses in AIDS Care
Issue number5
StatePublished - Jan 1 2005


  • Antiretroviral
  • HIV
  • Neurologic and psychologic complications

ASJC Scopus subject areas

  • Advanced and Specialized Nursing


Dive into the research topics of 'Neurologic and psychiatric complications of antiretroviral agents'. Together they form a unique fingerprint.

Cite this